Sartorius Stedim Biotech S.A Key Executives
This section highlights Sartorius Stedim Biotech S.A's key executives, including their titles and compensation details.
Find Contacts at Sartorius Stedim Biotech S.A
(Showing 0 of )
Sartorius Stedim Biotech S.A Earnings
This section highlights Sartorius Stedim Biotech S.A's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
Time:
Est. EPS:
$-
Status:
Unconfirmed
Last Earnings Results
Date:
April 16, 2025
EPS:
$-
Est. EPS:
$0.94
Revenue:
$-
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q3 | 2024 | 2024-10-18 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-07-19 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-01-26 | $0.84 | $0.72 |
| Read Transcript | Q3 | 2023 | 2023-10-20 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-07-21 | $2.13 | $1.19 |
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Healthcare
Medical - Instruments & Supplies
$190.25
Stock Price
$18.51B
Market Cap
-
Employees
Aubagne, None
Location
Financial Statements
Access annual & quarterly financial statements for Sartorius Stedim Biotech S.A, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $2.78B | $2.78B | $3.49B | $2.89B | $1.91B |
| Cost of Revenue | $1.57B | $1.54B | $1.66B | $1.33B | $907.35M |
| Gross Profit | $1.21B | $1.23B | $1.83B | $1.55B | $1.00B |
| Gross Profit Ratio | 43.41% | 44.44% | 52.52% | 53.79% | 52.50% |
| Research and Development Expenses | $144.10M | $129.50M | $132.40M | $110.49M | $84.45M |
| General and Administrative Expenses | $168.70M | $167.10M | $154.70M | $126.12M | $95.49M |
| Selling and Marketing Expenses | $479.80M | $449.10M | $446.50M | $405.65M | $296.05M |
| Selling General and Administrative Expenses | $648.50M | $616.20M | $601.20M | $531.76M | $391.54M |
| Other Expenses | $43.50M | $- | $18.10M | $27.77M | $23.89M |
| Operating Expenses | $836.10M | $749.00M | $751.70M | $670.02M | $499.88M |
| Cost and Expenses | $2.41B | $2.29B | $2.41B | $2.00B | $1.41B |
| Interest Income | $18.90M | $6.20M | $500.00K | $276.00K | $509.00K |
| Interest Expense | $149.60M | $117.00M | $18.60M | $10.40M | $6.82M |
| Depreciation and Amortization | $301.70M | $237.60M | $181.70M | $141.56M | $101.69M |
| EBITDA | $670.50M | $755.70M | $1.35B | $811.96M | $623.79M |
| EBITDA Ratio | 24.12% | 27.23% | 38.74% | 28.12% | 32.66% |
| Operating Income | $370.60M | $484.50M | $995.20M | $683.30M | $471.81M |
| Operating Income Ratio | 13.33% | 17.46% | 28.49% | 23.67% | 24.70% |
| Total Other Income Expenses Net | $-151.40M | $-83.40M | $135.20M | $-36.60M | $-11.02M |
| Income Before Tax | $219.20M | $401.10M | $1.13B | $646.72M | $482.63M |
| Income Before Tax Ratio | 7.88% | 14.45% | 32.36% | 22.40% | 25.27% |
| Income Tax Expense | $40.70M | $89.00M | $250.50M | $232.41M | $122.11M |
| Net Income | $175.10M | $309.70M | $876.10M | $414.40M | $335.93M |
| Net Income Ratio | 6.30% | 11.16% | 25.08% | 14.35% | 17.59% |
| EPS | $1.81 | $3.36 | $9.51 | $4.50 | $3.64 |
| EPS Diluted | $1.81 | $3.36 | $9.51 | $4.50 | $3.64 |
| Weighted Average Shares Outstanding | 96.78M | 92.16M | 92.16M | 92.18M | 92.18M |
| Weighted Average Shares Outstanding Diluted | 96.78M | 92.16M | 92.16M | 92.18M | 92.18M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $751.30M | $655.40M | $706.40M | $666.90M | $706.80M | $666.90M | $675.70M | $726.10M | $890.00M | $878.40M | $861.80M | $862.50M | $778.18M | $757.00M | $696.70M | $655.20M | $530.68M | $510.40M | $447.00M | $422.10M |
| Cost of Revenue | $435.00M | $380.00M | $400.10M | $358.50M | $453.60M | $386.00M | $350.80M | $351.60M | $416.90M | $417.40M | $415.90M | $408.00M | $370.87M | $347.10M | $312.40M | $303.40M | $260.85M | $234.40M | $212.40M | $199.40M |
| Gross Profit | $316.30M | $275.40M | $306.30M | $308.40M | $253.20M | $280.90M | $324.90M | $374.50M | $473.10M | $461.00M | $445.90M | $454.50M | $407.30M | $409.90M | $384.30M | $351.80M | $269.83M | $276.00M | $234.60M | $222.70M |
| Gross Profit Ratio | 42.10% | 42.02% | 43.36% | 46.24% | 35.82% | 42.12% | 48.08% | 51.58% | 53.16% | 52.48% | 51.74% | 52.70% | 52.34% | 54.15% | 55.16% | 53.69% | 50.85% | 54.08% | 52.48% | 52.76% |
| Research and Development Expenses | $37.10M | $37.30M | $35.20M | $34.50M | $37.00M | $28.40M | $28.80M | $35.40M | $38.50M | $28.90M | $31.70M | $33.30M | $31.19M | $27.10M | $27.60M | $24.70M | $23.85M | $22.00M | $18.60M | $19.90M |
| General and Administrative Expenses | $52.40M | $37.30M | $39.40M | $39.60M | $55.10M | $39.50M | $35.00M | $37.50M | $39.30M | $38.90M | $35.50M | $40.90M | $40.92M | $25.00M | $32.30M | $27.90M | $25.49M | $23.70M | $24.10M | $22.10M |
| Selling and Marketing Expenses | $121.60M | $118.40M | $118.90M | $121.10M | $115.50M | $110.20M | $108.20M | $115.30M | $113.00M | $115.70M | $108.10M | $109.70M | $114.65M | $101.90M | $98.30M | $90.80M | $75.65M | $75.60M | $73.20M | $71.10M |
| Selling General and Administrative Expenses | $174.00M | $155.70M | $158.30M | $160.70M | $170.60M | $149.70M | $143.20M | $152.80M | $152.30M | $154.60M | $143.60M | $150.60M | $155.56M | $126.90M | $130.60M | $118.70M | $101.14M | $99.30M | $97.30M | $93.20M |
| Other Expenses | $-4.40M | $- | $35.20M | $- | $- | $- | $- | $32.60M | $-27.60M | $23.10M | $13.30M | $9.30M | $-18.53M | $26.10M | $9.20M | $10.90M | $-5.81M | $8.90M | $13.20M | $7.40M |
| Operating Expenses | $206.70M | $193.00M | $193.50M | $195.20M | $207.60M | $204.10M | $212.00M | $220.80M | $163.20M | $206.60M | $188.60M | $193.20M | $168.22M | $180.10M | $167.40M | $154.30M | $119.18M | $130.20M | $129.10M | $120.50M |
| Cost and Expenses | $641.70M | $573.00M | $593.60M | $553.70M | $661.20M | $590.10M | $562.80M | $572.40M | $580.10M | $624.00M | $604.50M | $601.20M | $539.10M | $527.20M | $479.80M | $457.70M | $380.03M | $364.60M | $341.50M | $319.90M |
| Interest Income | $-21.40M | $2.60M | $12.80M | $33.10M | $17.00M | $30.60M | $72.90M | $15.30M | $- | $35.10M | $37.20M | $87.50M | $51.20M | $3.90M | $2.90M | $8.70M | $37.36M | $4.50M | $1.60M | $5.40M |
| Interest Expense | $11.20M | $37.90M | $51.70M | $- | $64.00M | $41.40M | $26.80M | $20.40M | $- | $16.00M | $11.30M | $11.00M | $- | $24.20M | $17.00M | $35.30M | $12.54M | $7.90M | $12.00M | $5.50M |
| Depreciation and Amortization | $80.60M | $76.20M | $74.50M | $70.40M | $62.50M | $76.10M | $50.40M | $48.60M | $56.10M | $42.20M | $42.70M | $40.70M | $35.86M | $39.40M | $33.90M | $31.50M | $31.38M | $25.10M | $23.40M | $21.50M |
| EBITDA | $132.70M | $149.60M | $191.70M | $196.00M | $184.60M | $152.90M | $236.10M | $217.60M | $304.40M | $331.80M | $300.00M | $302.00M | $264.17M | $273.10M | $253.70M | $238.60M | $188.25M | $176.00M | $131.60M | $128.20M |
| EBITDA Ratio | 17.66% | 22.83% | 27.14% | 29.39% | 26.12% | 22.93% | 34.94% | 29.97% | 34.20% | 37.77% | 34.81% | 35.01% | 33.95% | 36.08% | 36.41% | 36.42% | 35.47% | 34.48% | 29.44% | 30.37% |
| Operating Income | $109.60M | $82.40M | $112.80M | $113.20M | $45.60M | $76.90M | $185.70M | $169.00M | $216.20M | $289.50M | $294.50M | $348.80M | $-1.08M | $229.80M | $216.90M | $197.50M | $150.65M | $145.80M | $105.50M | $102.20M |
| Operating Income Ratio | 14.59% | 12.57% | 15.97% | 16.97% | 6.45% | 11.53% | 27.48% | 23.28% | 24.29% | 32.96% | 34.17% | 40.44% | -0.14% | 30.36% | 31.13% | 30.14% | 28.39% | 28.57% | 23.60% | 24.21% |
| Total Other Income Expenses Net | $-68.70M | $-46.90M | $-38.90M | $-36.20M | $-68.70M | $-41.30M | $46.00M | $-5.10M | $-45.60M | $-16.00M | $-11.30M | $76.50M | $-175.16M | $-20.30M | $-10.60M | $-37.50M | $-6.42M | $-3.40M | $-8.90M | $-7.60M |
| Income Before Tax | $40.90M | $35.50M | $65.40M | $77.00M | $58.10M | $35.50M | $158.90M | $148.60M | $235.90M | $273.50M | $283.20M | $337.80M | $63.82M | $209.50M | $202.80M | $170.90M | $144.23M | $142.40M | $95.10M | $102.00M |
| Income Before Tax Ratio | 5.44% | 5.42% | 9.26% | 11.55% | 8.22% | 5.32% | 23.52% | 20.47% | 26.51% | 31.14% | 32.86% | 39.17% | 8.20% | 27.68% | 29.11% | 26.08% | 27.18% | 27.90% | 21.28% | 24.16% |
| Income Tax Expense | $-5.40M | $9.20M | $16.80M | $20.00M | $16.90M | $9.20M | $25.80M | $37.10M | $46.20M | $68.50M | $68.50M | $67.40M | $56.91M | $63.10M | $58.30M | $54.10M | $29.11M | $39.20M | $27.60M | $26.50M |
| Net Income | $45.60M | $25.50M | $47.60M | $56.00M | $39.80M | $25.70M | $133.10M | $111.10M | $186.70M | $200.60M | $214.80M | $270.20M | $8.21M | $148.80M | $148.50M | $125.80M | $114.25M | $99.80M | $66.40M | $74.70M |
| Net Income Ratio | 6.07% | 3.89% | 6.74% | 8.40% | 5.63% | 3.85% | 19.70% | 15.30% | 20.98% | 22.84% | 24.92% | 31.33% | 1.06% | 19.66% | 21.31% | 19.20% | 21.53% | 19.55% | 14.85% | 17.70% |
| EPS | $0.47 | $0.26 | $0.49 | $0.58 | $0.43 | $0.28 | $1.44 | $1.21 | $2.03 | $2.18 | $2.33 | $2.93 | $0.07 | $1.61 | $1.61 | $1.36 | $1.24 | $1.08 | $0.72 | $0.81 |
| EPS Diluted | $0.47 | $0.26 | $0.49 | $0.58 | $0.43 | $0.28 | $1.44 | $1.21 | $2.03 | $2.18 | $2.33 | $2.93 | $0.07 | $1.61 | $1.61 | $1.36 | $1.24 | $1.08 | $0.72 | $0.81 |
| Weighted Average Shares Outstanding | 96.78M | 98.08M | 97.32M | 96.72M | 92.16M | 92.17M | 92.17M | 92.17M | 92.17M | 92.02M | 92.18M | 92.18M | 92.17M | 92.18M | 92.18M | 92.34M | 91.82M | 92.27M | 92.22M | 92.22M |
| Weighted Average Shares Outstanding Diluted | 96.78M | 98.08M | 97.32M | 96.72M | 92.16M | 92.17M | 92.17M | 92.17M | 92.17M | 92.12M | 92.19M | 92.18M | 92.31M | 92.42M | 92.24M | 92.50M | 92.18M | 92.41M | 92.22M | 92.22M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $678.90M | $116.60M | $107.10M | $223.63M | $59.76M |
| Short Term Investments | $9.90M | $9.50M | $25.90M | $13.72M | $9.84M |
| Cash and Short Term Investments | $688.80M | $126.10M | $133.00M | $237.35M | $69.61M |
| Net Receivables | $- | $293.70M | $418.60M | $371.72M | $263.96M |
| Inventory | $684.90M | $882.40M | $1.02B | $782.95M | $472.31M |
| Other Current Assets | $367.30M | $112.90M | $95.90M | $77.33M | $79.19M |
| Total Current Assets | $1.74B | $1.42B | $1.67B | $1.46B | $875.22M |
| Property Plant Equipment Net | $1.89B | $1.63B | $1.29B | $928.41M | $643.95M |
| Goodwill | $2.91B | $2.85B | $1.14B | $820.70M | $875.16M |
| Intangible Assets | $1.63B | $1.74B | $876.90M | $684.42M | $633.52M |
| Goodwill and Intangible Assets | $4.54B | $4.58B | $2.01B | $1.51B | $1.51B |
| Long Term Investments | $14.10M | $40.80M | $-1.00M | $1.05M | $3.65M |
| Tax Assets | $63.20M | $69.70M | $61.60M | $46.51M | $27.48M |
| Other Non-Current Assets | $13.50M | $72.40M | $28.10M | $14.38M | $10.35M |
| Total Non-Current Assets | $6.52B | $6.32B | $3.39B | $2.50B | $2.19B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $8.26B | $7.74B | $5.07B | $3.95B | $3.07B |
| Account Payables | $310.00M | $258.50M | $251.50M | $251.30M | $174.73M |
| Short Term Debt | $64.60M | $79.10M | $24.00M | $40.40M | $23.99M |
| Tax Payables | $123.20M | $189.40M | $209.60M | $165.03M | $71.52M |
| Deferred Revenue | $- | $186.00M | $234.10M | $660.20M | $313.65M |
| Other Current Liabilities | $441.00M | $224.30M | $316.70M | $580.37M | $165.36M |
| Total Current Liabilities | $938.80M | $937.30M | $1.04B | $1.04B | $567.69M |
| Long Term Debt | $2.81B | $3.60B | $1.11B | $585.07M | $563.12M |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $358.20M | $399.80M | $178.30M | $125.83M | $98.58M |
| Other Non-Current Liabilities | $130.60M | $126.70M | $403.60M | $469.85M | $264.77M |
| Total Non-Current Liabilities | $3.29B | $4.13B | $1.52B | $1.18B | $1.02B |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $4.23B | $5.07B | $2.55B | $2.22B | $1.59B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $19.50M | $18.40M | $18.40M | $18.44M | $18.44M |
| Retained Earnings | $2.54B | $2.39B | $2.18B | $1.41B | $1.21B |
| Accumulated Other Comprehensive Income Loss | $- | $228.90M | $251.90M | $251.81M | $210.41M |
| Other Total Stockholders Equity | $1.42B | $600.00K | $251.90M | $-11.68M | $- |
| Total Stockholders Equity | $3.99B | $2.64B | $2.45B | $1.66B | $1.46B |
| Total Equity | $4.02B | $2.67B | $2.51B | $1.73B | $1.48B |
| Total Liabilities and Stockholders Equity | $8.26B | $7.74B | $5.07B | $3.95B | $3.07B |
| Minority Interest | $37.20M | $35.30M | $64.90M | $77.36M | $22.88M |
| Total Liabilities and Total Equity | $8.26B | $7.74B | $5.07B | $3.95B | $3.07B |
| Total Investments | $24.00M | $40.80M | $24.90M | $14.77M | $13.50M |
| Total Debt | $2.87B | $3.68B | $1.14B | $625.52M | $586.78M |
| Net Debt | $2.19B | $3.57B | $1.03B | $401.89M | $527.02M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $678.90M | $482.60M | $454.10M | $695.10M | $116.60M | $99.30M | $110.00M | $94.00M | $107.10M | $145.50M | $156.10M | $165.10M | $223.63M | $226.80M | $254.70M | $149.40M | $59.76M | $165.90M | $89.30M | $69.90M |
| Short Term Investments | $9.90M | $18.20M | $- | $32.60M | $9.50M | $19.40M | $14.30M | $19.00M | $25.90M | $16.20M | $24.90M | $47.10M | $13.72M | $9.70M | $- | $15.20M | $9.84M | $65.50M | $- | $48.70M |
| Cash and Short Term Investments | $688.80M | $500.80M | $454.10M | $695.10M | $116.60M | $118.70M | $124.30M | $113.00M | $133.00M | $161.70M | $181.00M | $212.20M | $237.35M | $236.50M | $254.70M | $164.60M | $69.61M | $231.40M | $89.30M | $118.60M |
| Net Receivables | $- | $316.20M | $297.50M | $332.80M | $293.70M | $305.80M | $323.80M | $- | $418.60M | $446.50M | $- | $408.70M | $371.72M | $358.10M | $320.30M | $308.20M | $263.96M | $- | $232.10M | $- |
| Inventory | $684.90M | $745.70M | $797.10M | $872.70M | $882.40M | $992.00M | $1.03B | $1.06B | $1.02B | $1.06B | $964.10M | $857.50M | $782.95M | $703.90M | $599.60M | $534.80M | $472.31M | $437.50M | $407.90M | $340.50M |
| Other Current Assets | $367.30M | $57.80M | $148.90M | $177.00M | $122.40M | $108.50M | $127.60M | $84.40M | $95.90M | $114.10M | $96.80M | $84.90M | $77.33M | $99.00M | $77.40M | $69.40M | $80.46M | $104.50M | $87.50M | $78.60M |
| Total Current Assets | $1.74B | $1.62B | $1.70B | $2.08B | $1.42B | $1.52B | $1.62B | $1.65B | $1.67B | $1.78B | $1.70B | $1.56B | $1.46B | $1.39B | $1.25B | $1.06B | $875.22M | $961.20M | $816.80M | $704.30M |
| Property Plant Equipment Net | $1.89B | $1.75B | $1.72B | $1.68B | $1.63B | $1.56B | $1.46B | $1.36B | $1.29B | $1.19B | $1.07B | $986.60M | $928.41M | $799.80M | $726.00M | $693.80M | $643.95M | $566.40M | $561.70M | $549.60M |
| Goodwill | $2.91B | $2.90B | $2.90B | $2.86B | $2.85B | $2.32B | $1.15B | $1.14B | $1.14B | $1.13B | $836.10M | $832.40M | $820.70M | $934.70M | $866.80M | $880.10M | $875.16M | $459.00M | $463.10M | $423.10M |
| Intangible Assets | $1.63B | $1.64B | $1.66B | $1.72B | $1.74B | $2.45B | $879.40M | $870.60M | $876.90M | $917.30M | $699.10M | $705.30M | $684.42M | $805.50M | $631.60M | $632.30M | $633.52M | $338.80M | $347.40M | $182.00M |
| Goodwill and Intangible Assets | $4.54B | $4.54B | $4.56B | $4.58B | $4.59B | $4.77B | $2.03B | $2.01B | $2.01B | $2.04B | $1.54B | $1.54B | $1.51B | $1.74B | $1.50B | $1.51B | $1.51B | $797.80M | $810.50M | $605.10M |
| Long Term Investments | $14.10M | $35.10M | $36.70M | $41.00M | $40.80M | $18.70M | $10.00M | $5.60M | $-1.00M | $-800.00K | $-9.90M | $-32.20M | $1.05M | $4.70M | $14.90M | $-1.30M | $3.65M | $-51.40M | $14.50M | $-33.90M |
| Tax Assets | $63.20M | $56.80M | $58.90M | $62.00M | $71.70M | $55.40M | $57.50M | $62.20M | $61.60M | $64.30M | $60.60M | $55.60M | $46.51M | $33.40M | $30.00M | $30.60M | $27.48M | $21.30M | $20.00M | $20.90M |
| Other Non-Current Assets | $13.50M | $1.60M | $2.50M | $2.50M | $2.70M | $21.80M | $17.10M | $21.40M | $28.10M | $16.90M | $25.50M | $47.70M | $14.38M | $10.20M | $600.00K | $15.70M | $10.35M | $66.20M | $600.00K | $49.40M |
| Total Non-Current Assets | $6.52B | $6.38B | $6.37B | $6.36B | $6.34B | $6.43B | $3.57B | $3.45B | $3.39B | $3.32B | $2.68B | $2.60B | $2.50B | $2.59B | $2.27B | $2.25B | $2.19B | $1.40B | $1.41B | $1.19B |
| Other Assets | $- | $- | $1 | $- | $- | $- | $- | $100.00K | $- | $-100.00K | $-100.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $8.26B | $8.00B | $8.07B | $8.44B | $7.75B | $7.96B | $5.19B | $5.10B | $5.07B | $5.10B | $4.38B | $4.16B | $3.95B | $3.98B | $3.52B | $3.31B | $3.07B | $2.36B | $2.22B | $1.90B |
| Account Payables | $310.00M | $192.80M | $203.20M | $402.80M | $444.50M | $412.10M | $440.40M | $454.90M | $485.60M | $520.30M | $520.80M | $506.00M | $251.30M | $439.80M | $407.40M | $364.60M | $174.73M | $239.00M | $222.10M | $199.10M |
| Short Term Debt | $64.60M | $32.00M | $152.10M | $-247.00M | $79.10M | $34.10M | $27.00M | $194.60M | $24.00M | $73.70M | $146.20M | $43.80M | $40.40M | $63.80M | $39.40M | $40.30M | $23.99M | $29.10M | $33.60M | $35.30M |
| Tax Payables | $123.20M | $138.50M | $139.50M | $133.60M | $189.40M | $160.00M | $200.90M | $215.30M | $209.60M | $208.00M | $226.00M | $205.00M | $165.03M | $155.40M | $111.90M | $98.20M | $71.52M | $73.50M | $56.10M | $63.30M |
| Deferred Revenue | $- | $189.00M | $199.90M | $133.60M | $189.40M | $313.90M | $360.50M | $- | $- | $- | $403.20M | $376.70M | $660.20M | $362.80M | $275.10M | $230.10M | $313.65M | $202.50M | $180.80M | $148.40M |
| Other Current Liabilities | $441.00M | $205.60M | $179.10M | $217.10M | $224.30M | $247.40M | $253.70M | $286.70M | $316.70M | $390.30M | $265.20M | $270.60M | $580.37M | $279.60M | $233.70M | $204.90M | $297.45M | $195.10M | $181.10M | $136.00M |
| Total Current Liabilities | $938.80M | $757.90M | $873.80M | $975.40M | $937.30M | $853.60M | $922.00M | $1.15B | $1.04B | $1.19B | $1.16B | $1.03B | $1.04B | $938.60M | $792.40M | $708.00M | $567.69M | $536.70M | $492.90M | $433.70M |
| Long Term Debt | $2.81B | $2.80B | $2.77B | $3.08B | $3.60B | $3.76B | $1.33B | $1.11B | $1.11B | $1.09B | $586.00M | $587.10M | $585.07M | $579.30M | $570.50M | $568.90M | $562.95M | $301.50M | $299.00M | $80.80M |
| Deferred Revenue Non-Current | $- | $- | $83.40M | $94.10M | $93.10M | $151.30M | $- | $- | $- | $- | $- | $- | $- | $546.80M | $371.80M | $- | $- | $99.50M | $99.20M | $- |
| Deferred Tax Liabilities Non-Current | $358.20M | $375.40M | $378.60M | $392.20M | $411.50M | $565.30M | $181.00M | $177.20M | $178.30M | $157.50M | $120.80M | $123.90M | $125.83M | $148.10M | $94.00M | $96.40M | $98.58M | $46.10M | $45.00M | $37.30M |
| Other Non-Current Liabilities | $130.60M | $125.70M | $125.30M | $126.20M | $126.80M | $100.00K | $149.90M | $201.40M | $403.60M | $306.00M | $382.70M | $422.70M | $469.85M | $546.70M | $100.00K | $383.50M | $455.78M | $100.00K | $100.00K | $97.70M |
| Total Non-Current Liabilities | $3.29B | $3.30B | $3.27B | $3.60B | $4.14B | $4.48B | $1.66B | $1.49B | $1.52B | $1.56B | $1.09B | $1.13B | $1.18B | $1.27B | $1.04B | $1.05B | $1.02B | $447.20M | $443.30M | $215.80M |
| Other Liabilities | $- | $- | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $4.23B | $4.06B | $4.14B | $4.57B | $5.08B | $5.33B | $2.58B | $2.64B | $2.55B | $2.75B | $2.25B | $2.16B | $2.22B | $2.21B | $1.83B | $1.76B | $1.59B | $983.90M | $936.20M | $649.50M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1 | $- | $- |
| Common Stock | $19.50M | $19.50M | $19.50M | $19.50M | $18.40M | $18.40M | $18.40M | $18.40M | $18.40M | $18.40M | $18.40M | $18.40M | $18.44M | $18.40M | $18.40M | $18.40M | $18.44M | $18.40M | $18.40M | $18.40M |
| Retained Earnings | $2.54B | $2.46B | $2.43B | $2.39B | $2.39B | $2.34B | $2.30B | $2.17B | $2.18B | $2.02B | $1.80B | $1.67B | $1.41B | $1.42B | $1.42B | $1.28B | $1.21B | $1.10B | $1.01B | $976.90M |
| Accumulated Other Comprehensive Income Loss | $- | $- | $1.44B | $1.42B | $228.90M | $231.50M | $231.60M | $231.50M | $251.90M | $231.50M | $282.40M | $231.60M | $251.81M | $231.50M | $223.90M | $231.60M | $210.41M | $231.50M | $231.20M | $231.50M |
| Other Total Stockholders Equity | $1.42B | $1.42B | $5.00M | $- | $- | $- | $1 | $100.00K | $251.90M | $100.00K | $- | $- | $-11.68M | $- | $- | $1 | $- | $- | $400.00K | $1 |
| Total Stockholders Equity | $3.99B | $3.90B | $3.89B | $3.83B | $2.64B | $2.59B | $2.57B | $2.42B | $2.45B | $2.27B | $2.05B | $1.92B | $1.66B | $1.67B | $1.67B | $1.53B | $1.46B | $1.35B | $1.26B | $1.23B |
| Total Equity | $4.02B | $3.94B | $3.92B | $3.87B | $2.67B | $2.63B | $2.60B | $2.45B | $2.51B | $2.35B | $2.13B | $2.00B | $1.73B | $1.76B | $1.69B | $1.56B | $1.48B | $1.38B | $1.29B | $1.25B |
| Total Liabilities and Stockholders Equity | $8.26B | $8.00B | $8.07B | $8.44B | $7.75B | $7.96B | $5.19B | $5.10B | $5.07B | $5.10B | $4.38B | $4.16B | $3.95B | $3.98B | $3.52B | $3.31B | $3.07B | $2.36B | $2.22B | $1.90B |
| Minority Interest | $37.20M | $36.90M | $36.10M | $35.20M | $35.30M | $34.10M | $33.50M | $34.10M | $64.90M | $76.60M | $75.90M | $76.50M | $77.36M | $95.10M | $24.60M | $25.30M | $22.88M | $30.40M | $29.00M | $19.10M |
| Total Liabilities and Total Equity | $8.26B | $8.00B | $8.07B | $8.44B | $7.75B | $7.96B | $5.19B | $5.10B | $5.07B | $5.10B | $4.38B | $4.16B | $3.95B | $3.98B | $3.52B | $3.31B | $3.07B | $2.36B | $2.22B | $1.90B |
| Total Investments | $24.00M | $35.10M | $36.70M | $41.00M | $40.80M | $38.10M | $24.30M | $24.60M | $24.90M | $15.40M | $15.00M | $14.90M | $14.77M | $14.40M | $14.90M | $13.90M | $13.50M | $14.10M | $14.50M | $14.80M |
| Total Debt | $2.87B | $2.83B | $2.92B | $3.19B | $3.68B | $3.79B | $1.36B | $1.31B | $1.14B | $1.17B | $732.20M | $630.90M | $625.52M | $643.10M | $609.90M | $609.20M | $586.78M | $330.60M | $332.60M | $116.10M |
| Net Debt | $2.19B | $2.35B | $2.46B | $2.49B | $3.57B | $3.69B | $1.25B | $1.21B | $1.03B | $1.02B | $576.10M | $465.80M | $401.89M | $416.30M | $355.20M | $459.80M | $527.02M | $164.70M | $243.30M | $46.20M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $219.20M | $309.70M | $1.13B | $646.72M | $482.63M |
| Depreciation and Amortization | $301.70M | $237.60M | $181.70M | $141.56M | $102.28M |
| Deferred Income Tax | $- | $- | $- | $-900.00K | $-879.00K |
| Stock Based Compensation | $- | $- | $- | $900.00K | $879.00K |
| Change in Working Capital | $251.00M | $190.70M | $-351.30M | $-145.75M | $-44.28M |
| Accounts Receivables | $- | $162.10M | $-65.80M | $-87.33M | $-73.89M |
| Inventory | $207.60M | $131.20M | $-217.90M | $-275.40M | $-117.31M |
| Accounts Payables | $- | $1 | $65.80M | $87.33M | $73.89M |
| Other Working Capital | $43.40M | $-102.60M | $-133.40M | $129.65M | $73.02M |
| Other Non Cash Items | $43.20M | $-108.30M | $-348.50M | $53.45M | $-123.75M |
| Net Cash Provided by Operating Activities | $815.10M | $629.70M | $612.30M | $695.97M | $416.88M |
| Investments in Property Plant and Equipment | $-339.80M | $-473.60M | $-430.60M | $-323.99M | $-159.19M |
| Acquisitions Net | $- | $-2.24B | $-515.60M | $-141.67M | $-470.62M |
| Purchases of Investments | $-100.00K | $- | $- | $-323.99M | $-159.19M |
| Sales Maturities of Investments | $- | $- | $- | $323.99M | $159.19M |
| Other Investing Activities | $-100.00K | $-8.20M | $-11.30M | $432.00K | $8.69M |
| Net Cash Used for Investing Activities | $-340.00M | $-2.72B | $-957.50M | $-465.23M | $-621.12M |
| Debt Repayment | $-861.90M | $2.32B | $392.40M | $-5.47M | $299.47M |
| Common Stock Issued | $1.19B | $1.30M | $- | $- | $- |
| Common Stock Repurchased | $-1.90M | $- | $-3.20M | $- | $- |
| Dividends Paid | $-67.10M | $-132.70M | $-116.10M | $-62.68M | $-31.34M |
| Other Financing Activities | $-177.80M | $-205.30M | $-52.40M | $-9.55M | $-34.06M |
| Net Cash Used Provided by Financing Activities | $84.90M | $1.99B | $220.70M | $-71.71M | $234.07M |
| Effect of Forex Changes on Cash | $2.30M | $-300.00K | $8.00M | $4.83M | $1.77M |
| Net Change in Cash | $562.30M | $9.50M | $-116.50M | $163.86M | $31.60M |
| Cash at End of Period | $678.90M | $116.60M | $107.10M | $223.63M | $59.76M |
| Cash at Beginning of Period | $116.60M | $107.10M | $223.60M | $59.76M | $28.17M |
| Operating Cash Flow | $815.10M | $629.70M | $612.30M | $695.97M | $416.88M |
| Capital Expenditure | $-339.80M | $-473.60M | $-430.60M | $-323.99M | $-159.19M |
| Free Cash Flow | $475.30M | $156.10M | $181.70M | $371.98M | $257.69M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $40.90M | $25.50M | $47.60M | $56.00M | $39.80M | $35.50M | $158.90M | $148.60M | $235.90M | $273.50M | $283.20M | $337.80M | $63.82M | $211.30M | $207.40M | $182.40M | $144.23M | $140.20M | $93.60M | $100.90M |
| Depreciation and Amortization | $80.60M | $76.20M | $74.50M | $70.40M | $62.50M | $76.10M | $50.40M | $48.60M | $56.10M | $42.20M | $42.80M | $40.60M | $35.86M | $37.60M | $32.60M | $31.50M | $31.38M | $25.10M | $23.40M | $21.50M |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $900.00K | $- | $- | $- | $879.00K | $- | $- | $- |
| Change in Working Capital | $138.50M | $90.60M | $39.20M | $-17.30M | $163.00M | $700.00K | $18.70M | $8.30M | $-33.10M | $-55.40M | $-161.90M | $-100.90M | $-38.35M | $-74.80M | $-28.30M | $-1.20M | $-18.28M | $-14.40M | $-15.80M | $8.80M |
| Accounts Receivables | $- | $25.90M | $50.90M | $-47.00M | $34.50M | $54.00M | $22.20M | $51.40M | $15.40M | $21.50M | $-62.20M | $-40.50M | $17.57M | $-52.60M | $-15.50M | $-36.80M | $-33.79M | $-25.80M | $-109.40M | $11.90M |
| Inventory | $76.00M | $43.10M | $72.50M | $16.00M | $99.30M | $51.70M | $26.60M | $-46.40M | $1.40M | $-67.10M | $-87.40M | $-64.80M | $-69.80M | $-85.60M | $-66.50M | $-53.40M | $-26.70M | $-37.70M | $-35.70M | $-12.60M |
| Accounts Payables | $- | $- | $- | $- | $-34.50M | $-54.00M | $-22.20M | $-51.40M | $-15.40M | $-21.50M | $62.20M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $62.50M | $21.60M | $-84.20M | $-33.30M | $63.70M | $-51.00M | $-7.90M | $54.70M | $-34.50M | $11.70M | $-74.50M | $-36.10M | $31.45M | $10.80M | $38.20M | $52.20M | $8.42M | $23.30M | $19.90M | $21.40M |
| Other Non Cash Items | $24.90M | $-66.80M | $55.00M | $63.60M | $-32.50M | $-13.90M | $-81.60M | $-39.90M | $-39.30M | $-114.90M | $-86.10M | $-105.80M | $101.05M | $-5.60M | $-47.60M | $-8.70M | $-67.75M | $-18.90M | $-20.40M | $-16.70M |
| Net Cash Provided by Operating Activities | $284.90M | $125.50M | $216.30M | $47.90M | $232.80M | $98.40M | $146.40M | $165.60M | $219.60M | $145.40M | $78.00M | $171.70M | $162.37M | $168.50M | $164.10M | $204.00M | $89.58M | $132.00M | $80.80M | $114.50M |
| Investments in Property Plant and Equipment | $-80.00M | $- | $-80.20M | $-109.20M | $-102.80M | $-108.90M | $-146.10M | $-115.80M | $-141.90M | $-108.80M | $-102.70M | $-77.20M | $-137.99M | $-72.60M | $-51.40M | $-62.00M | $-81.99M | $-26.80M | $-25.20M | $-25.20M |
| Acquisitions Net | $- | $- | $- | $- | $- | $-2.22B | $-22.70M | $-87.40M | $5.20M | $-475.90M | $200.00K | $-45.10M | $-2.97M | $-141.60M | $100.00K | $-100.00K | $-248.72M | $-4.00M | $-217.90M | $- |
| Purchases of Investments | $-100.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $-100.00K | $-70.40M | $- | $- | $-2.40M | $-5.80M | $- | $87.40M | $-11.30M | $100.00K | $-100.00K | $- | $-137.25M | $-71.80M | $-52.20M | $-62.20M | $-35.70M | $-36.30M | $-28.80M | $-49.70M |
| Net Cash Used for Investing Activities | $-80.20M | $-70.40M | $-80.20M | $-109.20M | $-105.20M | $-2.33B | $-168.80M | $-115.80M | $-148.00M | $-584.60M | $-102.60M | $-122.30M | $-140.23M | $-213.40M | $-52.20M | $-62.30M | $-284.42M | $-40.30M | $-246.70M | $-49.70M |
| Debt Repayment | $-5.40M | $-29.80M | $-275.70M | $-551.00M | $-112.50M | $2.22B | $47.50M | $163.80M | $-58.60M | $421.80M | $128.70M | $-99.50M | $-30.47M | $18.40M | $-4.60M | $11.20M | $117.27M | $16.70M | $185.80M | $-20.30M |
| Common Stock Issued | $2.20M | $- | $- | $1.19B | $1.30M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $600.00K | $3.10M | $-5.60M | $- | $500.00K | $1.60M | $-1.50M | $-600.00K | $400.00K | $3.10M | $-1.10M | $-5.60M | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $-67.10M | $- | $- | $- | $- | $-132.70M | $- | $- | $-116.10M | $- | $-17.00K | $- | $- | $-62.70M | $-41.00K | $-31.30M | $- | $- |
| Other Financing Activities | $-8.80M | $-133.10M | $-27.50M | $-900.00K | $-103.20M | $-1.20M | $-6.90M | $-94.00M | $-47.40M | $-900.00K | $-2.80M | $-2.40M | $-17.00K | $-700.00K | $-1.60M | $-1.00M | $-29.26M | $-800.00K | $-2.10M | $-1.90M |
| Net Cash Used Provided by Financing Activities | $-11.40M | $-159.80M | $-376.20M | $639.80M | $-110.70M | $2.22B | $39.10M | $-63.50M | $-105.60M | $424.00M | $8.70M | $-108.70M | $-30.71M | $17.70M | $-6.20M | $-52.50M | $87.97M | $-15.40M | $183.70M | $-22.20M |
| Effect of Forex Changes on Cash | $3.10M | $200.00K | $-900.00K | $-100.00K | $400.00K | $-600.00K | $-800.00K | $700.00K | $-4.30M | $4.50M | $7.10M | $700.00K | $5.43M | $-700.00K | $-300.00K | $400.00K | $667.00K | $300.00K | $1.70M | $-900.00K |
| Net Change in Cash | $196.30M | $28.50M | $-241.00M | $578.50M | $17.30M | $-10.70M | $16.00M | $-13.10M | $-38.40M | $-10.60M | $-9.00M | $-58.50M | $-3.17M | $-27.90M | $105.30M | $89.60M | $-106.14M | $76.60M | $19.40M | $41.70M |
| Cash at End of Period | $678.90M | $482.60M | $454.10M | $695.10M | $116.60M | $99.30M | $110.00M | $94.00M | $107.10M | $145.50M | $156.10M | $165.10M | $223.63M | $226.80M | $254.70M | $149.40M | $59.76M | $165.90M | $89.30M | $69.90M |
| Cash at Beginning of Period | $482.60M | $454.10M | $695.10M | $116.60M | $99.30M | $110.00M | $94.00M | $107.10M | $145.50M | $156.10M | $165.10M | $223.60M | $226.80M | $254.70M | $149.40M | $59.80M | $165.90M | $89.30M | $69.90M | $28.20M |
| Operating Cash Flow | $284.90M | $258.50M | $216.30M | $47.90M | $232.80M | $98.40M | $146.40M | $165.60M | $219.60M | $145.40M | $78.00M | $171.70M | $162.37M | $168.50M | $164.10M | $204.00M | $89.58M | $132.00M | $80.80M | $114.50M |
| Capital Expenditure | $-80.00M | $-70.40M | $-80.20M | $-109.20M | $-102.80M | $-108.90M | $-146.10M | $-115.80M | $-141.90M | $-108.80M | $-102.70M | $-77.20M | $-137.99M | $-72.60M | $-51.40M | $-62.00M | $-81.99M | $-26.80M | $-25.20M | $-25.20M |
| Free Cash Flow | $204.90M | $188.10M | $136.10M | $-61.30M | $130.00M | $-10.50M | $300.00K | $49.80M | $77.70M | $36.60M | $-24.70M | $94.50M | $24.38M | $95.90M | $112.70M | $142.00M | $7.59M | $105.20M | $55.60M | $89.30M |
Sartorius Stedim Biotech S.A Dividends
Explore Sartorius Stedim Biotech S.A's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
0.37%
Dividend Payout Ratio
38.32%
Dividend Paid & Capex Coverage Ratio
2.00x
Sartorius Stedim Biotech S.A Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.69 | $0.69 | April 02, 2025 | April 03, 2025 | April 04, 2025 |
Sartorius Stedim Biotech S.A News
Read the latest news about Sartorius Stedim Biotech S.A, including recent articles, headlines, and updates.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for DIM.PA.